Inside the PWN Books Series

In today’s LIVE-TALK podcast, we chat about our recently published series of books.  We highlight Dr. Blevins’ prolific writing output in the PWN self-published book series, with five titles on pituitary adenomas, diabetes insipidus, Cushing’s, hypopituitarism, and pituitary disorders; a TSH-producing tumor book (in editing); a prolactinoma volume heading to the publisher; and an acromegaly book planned.

After 36 Years a Breakthrough for Hypothalamic Obesity

Our live talk sessions of the pituitary and adrenal podcasts continue with this extremely informational conversation on hypothalamic obesity. If you are interested in learning more about his devastating disorder, please listen to Dr. Blevins as he shares his insights and extensive expertise on its causes, new treatments, and latest developments.

From AACE 2026: More on hypercortisolism and the hidden connection to high blood pressure and diabetes

From J D Faccinetti – PWN co-founder and chief editor – Hypercortisolism, also known as Cushing’s syndrome – not to be confused with Cushing’s disease (more on that below), is far more common in people

Seen, Heard, and Understood: Why Validation Is a Cornerstone of Pituitary Patient Care

In this article, we explore the concept of validation: what it means, why it matters so deeply for the pituitary patient community, and how a simple but genuine act of being truly heard can make a profound difference in health outcomes, relationships, and quality of life. From Linda M Rio, PWN contributor and mental health professional – Humans at our core are inherently social creatures whose psychological well-being is deeply influenced by the reactions of others.

It’s time to do something about insurance companies trying to play doctor

I’m losing my patience with insurance companies and pharmacy benefit managers. They are destroying medicine in their pursuit of wealth for investors and C-suite executives. Many things we do, from diagnostic and laboratory tests to medications, are being denied.

The science behind three-month Octreotide formulation

For those living with acromegaly, the daily challenges of managing their condition can be overwhelming. This podcast explores this new formulation of Octreotide that promises a significant shift in treatment protocols. With insights from Anne, we’ll dive into the details of this innovative approach, how it works, and why it matters for patients.

An important paper from Dr. Francesca Galbiati on hypothalamic obesity

HYPOTHALAMIC OBESITY: HOW TO HELP THE FIGHT AGAINST HUNGER-PROMOTING, EVOLUTIONARILY CONSERVED BRAIN NETWORKS From Francesca Galbiati, MD, neuroendocrinologist and neuroscientist,  Assistant Professor  medicine UCSF, and PWN contributing author – Tumors, surgery, traumatic brain injury, and